IRWD IRONWOOD PHARMACEUTICALS INC Expansion Plans 8-K Filing 2025 - Strategic Alternatives On April 14, 2025, Ironwood Pharmaceuticals announced it is exploring strategic alternatives for apraglutide, as detailed in their press release.Get access to all SEC 8-K filings of the IRONWOOD PHARMACEUTICALS INC